Veraxa Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
1.100
-0.030 (-2.65%)
Oct 30, 2026, 9:45 AM EDT - Market open
Veraxa Biotech AG Market Cap
Veraxa Biotech AG has a market cap or net worth of $155.55 million as of October 30, 2026. It is the 22,007th most valuable company in the world and the 3,773rd biggest in the United States. Its market cap has decreased by 53.20% in one year.
Market Cap
155.55M
Enterprise Value
154.95M
1-Year Change
-53.20%
Global Rank
Country Rank
#3,773 United States
Category
ChartMarket Cap Chart
Since September 30, 2024, Veraxa Biotech AG's market cap has decreased from $315.30M to $155.55M, a decrease of -50.67%. That is a compound annual growth rate of -28.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 155.55M | -53.90% |
| Dec 31, 2025 | 337.44M | 6.49% |
| Dec 30, 2024 | 316.88M | 0.50% |
| Sep 30, 2024 | 315.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 168.70M |
| PepGen | 166.92M |
| Acumen Pharmaceuticals | 165.63M |
| Canton Strategic Holdings | 163.35M |
| Entrada Therapeutics | 158.65M |
| Cue Biopharma | 155.82M |
| NervGen Pharma | 154.83M |
| MacroGenics | 151.61M |